49. 全身性エリテマトーデス Systemic lupus erythematosus Clinical trials / Disease details

臨床試験数 : 946 / 薬物数 : 722 - (DrugBank : 186) / 標的遺伝子数 : 117 - 標的パスウェイ数 : 199

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02102594 (ClinicalTrials.gov)	October 2014	25/3/2014	Therapy of Antibody-mediated Autoimmune Diseases by Bortezomib (TAVAB)	Therapy of Antibody-mediated Autoimmune Diseases by Bortezomib (TAVAB)	Myasthenia Gravis;Systemic Lupus Erythematosus;Rheumatoid Arthritis	Drug: Bortezomib	Charite University, Berlin, Germany	Prof. Dr. med. Falk Hiepe (Charité, Internal Medicine / Rheumathology);NeuroCure Clinical Research C ...	Terminated	18 Years	75 Years	All	11	Phase 2	Germany
2	JPRN-UMIN000012227	2013/11/06	06/11/2013	A phase II randomized trial of evaluation for boltezomib in refractory Systemic lupus erythematosus		Systemic lupus erythmatosus	bortezomib(1.3mg/m2) 2times/week total 8times. saline	Tohoku university hospital	NULL	Complete: follow-up complete	20years-old	65years-old	Male and Female	14	Phase 2	Japan

First Previous1Next Last